Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 4/20 | 1.00 |
| ▸ | CYP11B2 | P19099 | 4/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 3/20 | 1.00 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.66 |
| ▸ | MAOA | P21397 | 4/20 | 0.61 |
| ▸ | MAOB | P27338 | 4/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | CASP3 | P42574 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.56 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.56 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.56 |
| ▸ | IDO1 | P14902 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4413259 | 0.85 | CYP11B1 (0.73) | CYP11B1CYP11B2CYP19A1NCOA3MAOA | |
| Trifluoroacetic Acid SCHEMBL2072297 | 0.85 | CYP11B1 (0.73) | CYP11B1CYP11B2CYP19A1NCOA3MAOA | |
| Trifluoromethanesulfonic Acid SCHEMBL23277132 | 0.84 | CYP11B1 (0.71) | CYP11B1CYP11B2CYP19A1NCOA3MAOA | |
| SCHEMBL28274864 | 0.83 | CYP11B1 (0.71) | CYP11B1CYP11B2CYP19A1NCOA3MAOA | |
| SCHEMBL13045131 | 0.82 | CYP19A1 (1.00) | CYP11B1CYP11B2CYP19A1NCOA3MAOA | |
| SCHEMBL27931325 | 0.80 | CYP11B1 (0.67) | CYP11B1CYP11B2CYP19A1NCOA3MAOA | |
| SCHEMBL4499181 | 0.80 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP19A1NCOA3MAOA | |
| SCHEMBL15021420 | 0.80 | CYP19A1 (0.66) | CYP11B1CYP11B2CYP19A1NCOA3MAOA | |
| SCHEMBL30718021 | 0.80 | NCOA3 (1.00) | CYP11B1CYP11B2CYP19A1NCOA3MAOA | |
| SCHEMBL27703203 | 0.80 | NCOA3 (1.00) | CYP11B1CYP11B2CYP19A1NCOA3MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090221591-A1 | Selective Inhibitors of Human Corticosteroid Synthases | UNIVERSITAT DES SAARLANDES (DE) | 2009-09-03 | — | — | US | claimed |
| CN-111258180-B | Hexaarylbisimidazoles mixed photoinitiator and application thereof | 常州正洁智造科技有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-111258180-A | Hexaarylbisimidazole mixed photoinitiator and application thereof | 常州格林感光新材料有限公司 | 2020-06-09 | — | — | CN | disclosed |
| US-10011573-B2 | Human androgen receptor DNA-binding domain (DBD) compounds as therapeutics and methods for their use | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2018-07-03 | — | — | US | disclosed |
| US-10011573-B2 | Human androgen receptor DNA-binding domain (DBD) compounds as therapeutics and methods for their use | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2018-07-03 | — | — | US | disclosed |
| US-20170183319-A1 | HUMAN ANDROGEN RECEPTOR DNA-BINDING DOMAN (DBD) COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2017-06-29 | — | — | US | disclosed |
| US-20170183319-A1 | HUMAN ANDROGEN RECEPTOR DNA-BINDING DOMAN (DBD) COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2017-06-29 | — | — | US | disclosed |
| EP-1853261-B1 | SELECTIVE INHIBITORS OF HUMAN CORTICOSTEROID SYNTHASES | UNIV SAARLAND (DE) | 2017-01-11 | — | — | EP | disclosed |
| EP-1853261-B1 | SELECTIVE INHIBITORS OF HUMAN CORTICOSTEROID SYNTHASES | UNIV SAARLAND (DE) | 2017-01-11 | — | — | EP | disclosed |
| CN-103858028-B | Optical filter for solid-state imaging device, and solid-state imaging device and camera module using same | JSR株式会社 | 2016-12-28 | — | — | CN | disclosed |
| CN-101329882-A | Information recording medium and optical disc apparatus using the same | TOSHIBA KK (JP) | 2008-12-24 | — | — | CN | disclosed |
| CN-100378839-C | Information storage medium | TOKYO SHIBAURA ELECTRIC CO (JP) | 2008-04-02 | — | — | CN | disclosed |
| CN-101097744-A | Write once information recording medium and disk apparatus | TOSHIBA KK (JP) | 2008-01-02 | — | — | CN | disclosed |
| EP-1853261-A1 | SELECTIVE INHIBITORS OF HUMAN CORTICOSTEROID SYNTHASES | Universität des Saarlandes (DE) | 2007-11-14 | — | — | EP | disclosed |
| CN-101055737-A | Recordable information recording medium and disk apparatus | TOSHIBA KK (JP) | 2007-10-17 | — | — | CN | disclosed |
| WO-2006092430-A1 | SELECTIVE INHIBITORS OF HUMAN CORTICOSTEROID SYNTHASES | Universität des Saarlandes (DE) | 2006-09-08 | — | — | WO | disclosed |
| CN-1811943-A | Information storage medium | TOKYO SHIBAURA ELECTRIC CO (JP) | 2006-08-02 | — | — | CN | disclosed |
| CN-1694167-A | Write-once information recording medium | TOSHIBA KK (JP) | 2005-11-09 | — | — | CN | disclosed |
| CN-1684171-A | Recording material for medium | TOSHIBA CORP (JP) | 2005-10-19 | — | — | CN | disclosed |
| CN-1677527-A | Write-once information recording medium and coloring matter material therefor | TOKYO SHIBAURA ELECTRIC CO (JP) | 2005-10-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10011573-B2 | Human androgen receptor DNA-binding domain (DBD) compounds as therapeutics and methods for their use | AR, SHBG, BRCA1 | CYP11B1 138/4885CYP11B2 234/4885CYP19A1 6/4885 |
| US-20090221591-A1 | Selective Inhibitors of Human Corticosteroid Synthases | CYP11B1, HSD11B1, HSD17B1 | CYP11B1 1/4885CYP11B2 5/4885CYP19A1 59/4885 |
| US-20170183319-A1 | HUMAN ANDROGEN RECEPTOR DNA-BINDING DOMAN (DBD) COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE | AR, FSHR, ESRRB | CYP11B1 286/4885CYP11B2 389/4885CYP19A1 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.